Maximum quantity allowed is 999
CAS RN: 888504-28-7 | Product Number: P2220
Potassium 5-Methyl-1,3,4-oxadiazole-2-carboxylate

Purity: >98.0%(T)(HPLC)
- 5-Methyl-1,3,4-oxadiazole-2-carboxylic Acid Potassium Salt
Size | Unit Price | Hyderabad | Japan* | Quantity |
---|---|---|---|---|
200MG |
₹6,900.00
|
2 | 12 |
|
1G |
₹31,400.00
|
2 | 15 |
|
*Upon orders receipt, Hyderabad stocks will be dispatched on the same day.
*Items available in Japan warehouse will be dispatched in 10-12 working days.
*INR price is exclusive of domestic taxes applicable.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
Product Number | P2220 |
Purity / Analysis Method ![]() |
>98.0%(T)(HPLC) |
Molecular Formula / Molecular Weight | C__4H__3KN__2O__3 = 166.18 |
Physical State (20 deg.C) | Solid |
Storage Temperature ![]() |
Room Temperature (Recommended in a cool and dark place, <15°C) |
CAS RN | 888504-28-7 |
Reaxys Registry Number | 14557884 |
PubChem Substance ID | 354334121 |
MDL Number | MFCD08060085 |
Appearance | White to Almost white powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(Nonaqueous Titration) | min. 98.0 % |
NMR | confirm to structure |
References
- Discovery of Raltegravir, a Potent, Selective Orally Bioavailable HIV-Integrase Inhibitor for the Treatment of HIV-AIDS Infection
- Development of a Second-Generation, Highly Efficient Manufacturing Route for the HIV Integrase Inhibitor Raltegravir Potassium
- Identification, Synthesis, and Strategy For Minimization of Potential Impurities Observed In Raltegravir Potassium Drug Substance
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.